Four JAK Inhibitors Have Comparable Efficacy, Safety for RA

FRIDAY, Dec. 1, 2023 -- For patients with rheumatoid arthritis, the efficacy and safety of four Janus kinase (JAK) inhibitors is comparable, according to a study published online Nov. 1 in Rheumatology.
Shinya Hayashi, M.D., from the Kobe...